Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 4
1(16.7%)
6Total
N/A(5)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07237750Not ApplicableRecruiting

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

Role: collaborator

NCT07177586Not ApplicableRecruiting

New-Generation GMA Laryngeal Mask Airway Versus Conventional Inflatable Laryngeal Mask Airway

Role: collaborator

NCT07360002Not ApplicableNot Yet Recruiting

The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy

Role: collaborator

NCT06331923Not ApplicableRecruiting

Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes

Role: collaborator

NCT05540938Phase 4Recruiting

Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis

Role: collaborator

NCT06054087Not ApplicableUnknown

Effectiveness of Electroacupuncture in the Treatment of Diabetic Peripheral Neuropathy

Role: collaborator

All 6 trials loaded